ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near Portland, OR, USA:

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Portland, Oregon, United States and 43 other locations

This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...

Active, not recruiting
Non-Small Cell Lung Cancer Metastatic
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Drug: Patritumab Deruxtecan (Fixed dose)
Drug: Patritumab Deruxtecan (Up-Titration)

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Portland, Oregon, United States and 123 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

Portland, Oregon, United States and 30 other locations

study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...

Enrolling
Small Cell Lung Cancer
Drug: Topotecan
Drug: Amrubicin

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Portland, Oregon, United States and 220 other locations

sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) with high programmed cell death protein lig...

Enrolling
Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Drug: pemetrexed
Drug: LBL-007

Phase 2

BeiGene
BeiGene

Portland, Oregon, United States and 63 other locations

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Enrolling
Endometrial Cancer
Lung Cancer
Drug: Docetaxel
Drug: Carboplatin

Phase 1

Inspirna

Portland, Oregon, United States and 20 other locations

Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who progressed on First-Line Osimertinib Therapy. This study...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Cisplatin
Drug: Alectinib

Phase 2

AstraZeneca
AstraZeneca

Portland, Oregon, United States and 46 other locations

in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: encorafenib
Drug: binimetinib

Phase 2

Pfizer
Pfizer

Portland, Oregon, United States and 156 other locations

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...

Active, not recruiting
Small Cell Lung Cancer
Drug: Durvalumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Portland, Oregon, United States and 181 other locations

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer ...

Enrolling
Small Cell Lung Cancer
Drug: Alisertib

Phase 2

Puma Biotechnology
Puma Biotechnology

Vancouver, Washington, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems